Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.

Article Details

Citation

Motulsky HJ, Snavely MD, Hughes RJ, Insel PA

Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.

Circ Res. 1983 Feb;52(2):226-31.

PubMed ID
6297831 [ View in PubMed
]
Abstract

To determine the specificity of the previously demonstrated competition of verapamil with radioligand binding to alpha-adrenergic receptors, we examined the interaction of calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors on several tissues. Verapamil competed for [3H] prazosin binding to alpha 1-adrenergic receptors and for [3H]yohimbine binding to alpha 2-adrenergic receptors in several tissues (human platelets, rat kidney and heart, and cultured muscle cells) with dissociation constants of 0.6-6 microM. The calcium channel blockers D600, D591, fendiline, and prenylamine--which are structural analogues of verapamil--also competed for [3H]yohimbine binding to human platelets. Two other calcium channel blockers, diltiazem and nifedipine, did not compete for [3H] yohimbine binding to human platelets or [3H]prazosin binding to membranes prepared from rat ventricles. We used [3H]nitrendipine binding to identify putative calcium channels on rat myocardial membranes. Nifedipine and verapamil blocked these [3H]nitrendipine-binding sites on ventricular membranes, but epinephrine and prazosin did not, indicating that the ventricular alpha 1 receptors and calcium channels are distinct. We found no specific [3H]nitrendipine binding to human platelets. We conclude that the interaction of verapamil with alpha-adrenergic receptors is not receptor subtype or tissue specific, that interaction with alpha-adrenergic receptors is not a property of all calcium channel blockers, and that the interaction of verapamil with alpha-adrenergic receptors and its interaction with calcium channels occur at at least two distinct sites.

DrugBank Data that Cites this Article

Drugs
Drug Interactions
DrugsInteraction
Amiodarone
Phentolamine
The risk or severity of hypotension can be increased when Phentolamine is combined with Amiodarone.
Amiodarone
Propiomazine
The risk or severity of hypotension can be increased when Propiomazine is combined with Amiodarone.
Amiodarone
Tolazoline
The risk or severity of hypotension can be increased when Tolazoline is combined with Amiodarone.
Amiodarone
Phenoxybenzamine
The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Amiodarone.
Amiodarone
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Amiodarone.
Amiodarone
Periciazine
The risk or severity of hypotension can be increased when Periciazine is combined with Amiodarone.
Amiodarone
Acepromazine
The risk or severity of hypotension can be increased when Acepromazine is combined with Amiodarone.
Amiodarone
Thioproperazine
The risk or severity of hypotension can be increased when Thioproperazine is combined with Amiodarone.
Amiodarone
Pizotifen
The risk or severity of hypotension can be increased when Pizotifen is combined with Amiodarone.
Amiodarone
Indoramin
The risk or severity of hypotension can be increased when Indoramin is combined with Amiodarone.
Interactions
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more